What is Bristol-Myers Squibb's other revenue — total revenues?

Bristol-Myers Squibb (BMY) reported other revenue — total revenues of -$15.00M in Q1 2026.

What does other revenue — total revenues mean?

Revenue derived from non-core business activities and financial hedging instruments that is not generated by primary pharmaceutical product sales.

Products & Services · Total Revenues

Other revenue — Total Revenues

Analysis

StatementSegment

CategoryOther

SignalContext dependent

VolatilityVolatile

First reportedQ1 2025

Last reportedQ1 2026

Rolls up toTotal Revenue

How to read this metric

An increase may indicate successful financial hedging or growth in secondary business lines, while a decrease suggests reduced non-core income or unfavorable hedging outcomes.

Detailed definition

This metric represents revenue generated from activities outside of the company's core pharmaceutical product sales, inc...

Peer comparison

Peers often report this as 'Other Revenue' or 'Miscellaneous Income,' though the composition varies significantly based on the firm's hedging strategy and non-core asset portfolio.

Metric ID: bmy_segment_other_revenue_total_revenues

Historical Data

2 periods

	Q1 '25	Q1 '26
Value	$0.00	-$15.00M

Range-$15.00M – $0.00

Similar Metrics at Other Companies

AmgenAMGN View metric

Eli LillyLLY View metric

Regeneron PharmaceuticalsREGN View metric

CME GroupCME View metric

Deere & CompanyDE View metric

Regeneron PharmaceuticalsREGN View metric

Frequently Asked Questions

What is Bristol-Myers Squibb's other revenue — total revenues?: Bristol-Myers Squibb (BMY) reported other revenue — total revenues of -$15.00M in Q1 2026.
What does other revenue — total revenues mean?: Revenue derived from non-core business activities and financial hedging instruments that is not generated by primary pharmaceutical product sales.